Taken together, these data show that a possible relocation of TRAIL receptors from the cell surface, along with the concomitant depletion of Caspase-8 and a low p53 abundance, could be ultimately responsible for acquired AD-O51.4 resistance in CRC cell lines. The gene discussed is TP53; the disease is colorectal carcinoma.